Infections and the aging immune system in older adults
Part of Immune system & allergy clinical trials.
This study is looking at how infections and the aging immune system affect older adults. It compares people with an infection to healthy volunteers to understand how the body fights germs as we age.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 60 or older to be in the infection group, or be a healthy adult (any age) for the control group.
- For the healthy control group, you must have no current symptoms of infection (like fever, cough, or body aches).
- For the healthy control group, you need normal blood test results and no chronic diseases.
- For the infection group, you must have a doctor-diagnosed infection and be able to provide consent.
- You cannot have a serious illness that makes it hard to participate, like a tumor or autoimmune disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how the immune system works in people 60 and older, especially when they have an infection. Researchers want to understand why some older adults get sick more easily and develop better ways to prevent infections.
This study examines whether a simple aerobic exercise program (like walking or light aerobics) can help strengthen the immune system of older adults living in care homes. If you qualify, you would join a regular group exercise class, and researchers will check how your immune cells change over time.
This study aims to find normal levels of interferon (a natural protein that helps fight viruses) in healthy people aged 80 and older. It will help doctors better understand what is 'normal' for older adults.
This study is looking at how age affects the immune system's response to a pneumococcal vaccine. Researchers want to compare younger and older adults to see if immune cells change with age.
This study looks at how the body's inflammatory response (immune system markers) differs between older adults who have a current respiratory virus infection and those who don't. Researchers will measure these markers to better understand how the body fights these common infections.
This study looks at how the immune system works in people who have—or might have—an increased risk of infections. It also enrolls their healthy blood relatives so researchers can compare immune features; results may help doctors understand who is at higher risk and why.
Hear when a new Immunosenescence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.